Boghdadi, Anthony G. http://orcid.org/0000-0003-2944-7845
Spurrier, Joshua
Teo, Leon
Li, Mingfeng http://orcid.org/0000-0002-7959-6008
Skarica, Mario
Cao, Benjamin
Kwan, William C. http://orcid.org/0000-0002-3097-969X
Merson, Tobias D. http://orcid.org/0000-0002-7246-3608
Nilsson, Susan K.
Sestan, Nenad http://orcid.org/0000-0003-0966-9619
Strittmatter, Stephen M. http://orcid.org/0000-0001-8188-3092
Bourne, James A. http://orcid.org/0000-0002-0902-3108
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (APP108197, APP1077677)
Article History
Received: 11 January 2021
Accepted: 5 November 2021
First Online: 25 November 2021
Competing interests
: S.M.S. is a founder and equity holder in ReNetX Bio, Inc., which seeks clinical development of NgR1-FC (AXER-204) for spinal cord injury. The remaining authors declare no competing interests.